📢Check out our op-ed for @pharmaboardroom, where we lay out our aims for improving the access and reimbursement of comprehensive genomic profiling (#CGP) in Europe. ↪️@ExactSciences @GuardantHealth @illumina @MSDEurope @Novartis @EUCOPE.#oncology.

📢Check out our op-ed for @pharmaboardroom, where we lay out our aims for improving the access and reimbursement of comprehensive genomic profiling (#CGP) in Europe. ↪️@ExactSciences @GuardantHealth @illumina @MSDEurope @Novartis @EUCOPE.#oncology.

Join millions who have switched to Grok.

RT @ExactSciences: MCED tests have the potential to help catch more cancers earlier, when it may matter most. We appreciate @SenatorCardin'….

📢Check out our op-ed for @pharmaboardroom, where we lay out our aims for improving the access and reimbursement of comprehensive genomic profiling (#CGP) in Europe. ↪️@ExactSciences @GuardantHealth @illumina @MSDEurope @Novartis @EUCOPE .#oncology.

RT @EUCOPE: 🔑We need to re-think the relationship between testing and treatment in precision #oncology. 📃In this @pharmaboardroom op-ed, t….

RT @EUCOPE: "ECGP will address an important access gap for European #cancer patients and enable the shift of our healthcare systems towards….

🤝@MSDEurope is one of the founding partners of the @EU_CGP. Learn how #MSD, @EUCOPE and #ECGP will improve #cancer care through increased routine clinical access and reimbursement of CGP in Europe: ➡️ #genomics #personalizedmedicine #diagnostics #oncology

RT @EUCOPE: 🤝@MSDEurope is one of the founding partners of the @EU_CGP . Learn how #MSD and #ECGP will improve #cancer care through increas….

🤝 @Novartis is one of the founding partners of the.@EU_CGP. Learn how #Novartis @EUCOPE and #ECGP will improve #cancer care through increased routine clinical access and reimbursement of CGP in Europe: ➡️ #genomics #diagnostics #oncology

RT @EUCOPE: 🤝 @Novartis is one of the founding partners of the.@EU_CGP. Learn how #Novartis and #ECGP will improve #cancer care through inc….

RT @MSDEurope: We are thrilled to partner with @EU_CGP members to tackle limited access to targeted #cancercare. Let's foster #innovation t….

🤝 @ExactSciences is one of the founding partners of the #ECGP. Learn how Exact Sciences, @EUCOPE and ECGP will improve #cancer care through increased routine clinical access and reimbursement of #CGP in Europe:.➡️ #genomics #CGP

RT @EUCOPE: 🤝 @ExactSciences is one of the founding partners of the @EU_CGP. Learn how Exact Sciences and #ECGP will improve #cancer care t….

RT @EUCOPE: 😀We are happy to welcome @azafaros as the latest member to join EUCOPE. 🎯#Azafaros is a Dutch-based clinical-stage #biotech com….

🤝@GuardantHealth is one of the founding partners of the @EU_CGP. Learn how Guardant and #ECGP will improve #cancer care through increased routine clinical access and reimbursement of CGP in Europe: ➡️ #genomics #CGP

🗣️"The importance of CGP cannot be overestimated in guiding access to potentially life-saving treatments." - Bas Verhoef @illumina. Learn how @EU_CGP will improve #cancer care through increased routine clinical access and reimbursement of CGP in Europe: ➡️

📢The #ECGP is now live. 🎯Together with @EUCOPE @ExactSciences @GuardantHealth @illumina @MSDEurope @Novartis we aim to improve #cancer care through increased routine clinical access & reimbursement of #CGP.➡️ #genomics #CancerResearch #AdvancedDxs